APAC / Taiwanese Pharma Looking Locally for International Opportunities
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market,…
Taiwan
First Impressions / Taiwanese Pharma
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that is the envy of its neighbours. Here, three country managers for…
Report / New Taiwan Pharma Report November 2019 Out Now
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an…
Talent / Multinationals' HR Strategies in Taiwan
All country managers of multinational pharma companies need to strike the balance between having a global outlook…
In Conversation
Charles Chen – Vice Chairman & CEO, Medigen Vaccine Biologics Corp. (MVC)
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what MVC’s competitive advantages are. At MVC we have chosen a tried and tested technology platform as novel vaccine technologies face novel challenges Charles, could you start by introducing Medigen Vaccines Biologics Corp (MVC) and yourself as CEO to…
Taiwan Biotech Snapshot
Taiwan’s biotechnology industry was valued at USD 3.3 billion in 2016, representing around 26 percent of the…
Related Report
5 Biotechs to Watch in Taiwan
Taiwan has long been a leader in biotechnology research and development. With the government’s emphasis on…
Taiwan-US Research Team in MERS ‘Camel Flu’ Vaccine Breakthrough
Researchers from Taiwan and the USA may have found a vaccine for the Middle East respiratory syndrome coronavirus…
Investment / How Taiwan Can Benefit from the US-China Trade War
With the USA and China locked in a trade war, China’s near neighbour Taiwan – with its strong…
Is growth in the Taiwanese biotech sector a bubble that is about to burst?
In Taiwan, biotech is finally booming, and more and more of the companies benefitting from this boom are listing on…
Taiwan’s National Healthcare Insurance: Reform or Bust?
Taiwan boasts one of the most sophisticated and comprehensive public health systems in Asia. However, mounting…
Economic cooperation between Taiwan and China giving a boost to the Taiwanese…
Signed in June 2010, the Economic Cooperation Framework Agreement (ECFA) between Taiwan and China was set to reduce…
China / BioNTech-Fosun JV; Patent Law Revamp; Hong Kong as a Biotech Listing Hub
The latest news from Chinese pharma, including an overhaul of the country’s patent law; a BioNTech-Fosun tie-up…
APAC / Taiwanese Pharma Looking Locally for International Opportunities
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market,…
Company Profile / iXensor, Taiwan
Within Taiwan’s evolving medical device sector, many innovative startups are exploring breakthrough ideas which…
APAC / Taiwan's New Southbound Policy: Enhancing Regional Ties
In an effort to enhance trade and cooperation with other countries in the region and reduce dependency on mainland…
Report / New Taiwan Pharma Report November 2019 Out Now
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an…
First Impressions / Taiwanese Pharma
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that…
Taiwan: Preparing for takeoff
The past three years have been some of the most eventful in memory for Taiwan’s life sciences industry. At…